ImmunityBio's market cap is currently ―. The company's EPS TTM is $-1.126; its P/E ratio is -5.07; ImmunityBio is scheduled to report earnings on August 9, 2023, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 139.00K	$ 82.00K	$ 41.00K	$ 360.00K	$ 73.00K
Gross Profit	$ 139.00K	$ 82.00K	$ 41.00K	$ 360.00K	$ 73.00K
EBIT	$ -185.81M	$ -60.62M	$ -105.98M	$ -102.28M	$ -79.73M
EBITDA	$ -172.93M	$ -43.05M	-	$ -84.47M	$ -56.57M
Net Income Common Stockholders	$ -233.39M	$ -95.58M	$ -137.88M	$ -116.34M	$ -108.22M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 266.46M	$ 189.80M	$ 45.95M	$ 91.27M	$ 107.18M
Total Assets	$ 504.45M	$ 432.42M	$ 291.23M	$ 343.40M	$ 362.36M
Total Debt	$ 882.14M	$ 688.99M	$ 819.16M	$ 49.13M	$ 50.60M
Net Debt	$ 615.68M	$ 499.19M	$ 773.20M	$ -42.13M	$ -56.58M
Total Liabilities	$ 1.09B	$ 843.06M	$ 936.41M	$ 875.12M	$ 812.18M
Stockholders Equity	$ -586.99M	$ -411.72M	$ -642.12M	$ -528.98M	$ -447.33M
Cash Flow	-
Free Cash Flow	$ -123.23M	$ -93.08M	-	$ -92.70M	$ -109.63M
Operating Cash Flow	$ -115.27M	$ -87.40M	-	$ -84.28M	$ -90.70M
Investing Cash Flow	$ 2.25M	$ -15.63M	-	$ -8.48M	$ -18.89M
Financing Cash Flow	$ 200.54M	$ 237.50M	-	$ 76.89M	$ 109.94M

Currency in USD

ImmunityBio Earnings and Revenue History

Income Statement >

ImmunityBio Debt to Assets

Balance Sheet >

ImmunityBio Cash Flow

Cash Flow >

ImmunityBio Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing